Abiogenesis Clinpharm Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 195.04%
(FY 2020)
- Profit 319.64%
(FY 2020)
- Ebitda 526.80%
(FY 2020)
- Net Worth 162.99%
(FY 2020)
- Total Assets 208.24%
(FY 2020)
About Abiogenesis Clinpharm
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pawan Bhusari and Abraham Joseph serve as directors at the Company.
- CIN/LLPIN
U74930TG2014PTC096506
- Company No.
096506
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Abiogenesis Clinpharm?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Bhusari  | Director | 21-Nov-2014 | Current |
| Abraham Joseph | Director | 26-Jul-2019 | Current |
Financial Performance of Abiogenesis Clinpharm.
Abiogenesis Clinpharm Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 195.04% increase. The company also saw a substantial improvement in profitability, with a 319.64% increase in profit. The company's net worth Soared by an impressive increase of 162.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abiogenesis Clinpharm?
In 2020, Abiogenesis Clinpharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abiogenesis Clinpharm?
Abiogenesis Clinpharm has a workforce of 28 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abiogenesis Clinpharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abiogenesis Clinpharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
